ChloraSolv is approved for leg ulcers – doubles the potential market size in Europe

RLS Global, whose ambition is to be a leading research-driven platform company for wounds, has received regulatory approval that ChloraSolv can also be used for leg ulcers. This increases the potential market size by 100 percent. ChloraSolv has been approved for diabetic foot ulcers since 2019, where now leg ulcers also are included.ChloraSolv is a gel with antimicrobial properties that is used in cleansing wounds, so-called debridement. Without damaging the healthy tissue, ChloraSolv softens the dead tissue that prevents the wound from healing. The dead tissue can then be removed more